-

Food Delivery on the Rise Due to COVID-19 Lockdown - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--ResearchAndMarkets.com published a new article on the food and beverage industry, "Food Delivery on the Rise Due to COVID-19 Lockdown"

With more people stuck at home due to the COVID-19 outbreak, there has been a surge in demand for food delivery services. Since dine-in is no longer an option, consumers are turning to delivery to treat themselves during the days of social-distancing. Many delivery services such as Deliveroo, JustEat, Postmates and UberEats have responded to the crisis by introducing contactless delivery options to eliminate the risk of spreading the virus between the customer and driver.

Another factor driving demand for food delivery services is the increased number of restaurants offering home delivery. Since social-distancing measures forced restaurants and bars to close, many have switched to delivery to stay afloat during the pandemic. UberEats and Deliveroo have also recently expanded into grocery deliveries as a result of COVID-19. Both services recently announced partnerships with several supermarkets and convenience stores that will allow customers to order a selection of essential food, cleaning and hygiene products to be delivered to their homes.

To see the full article and a list of related reports on the market, visit "Food Delivery on the Rise Due to COVID-19 Lockdown"

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

$1.85 Bn Negative Carbon Portland Cement Global Markets, 2019-2024, 2024-2029F, 2034F - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Negative Carbon Portland Cement Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The negative carbon Portland cement market has experienced significant growth recently, with its size projected to expand from $0.64 billion in 2024 to $0.79 billion in 2025, at a robust CAGR of 24.1%. This growth is attributed to the rising demand for sustainable building materials, a heightened awareness of reducing carbon footprints, and regulatory sup...

$30+ Bn Hosted Private Branch Exchange (PBX) Markets, 2019-2024, 2024-2029F, 2034F - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hosted Private Branch Exchange Market Report 2025" has been added to ResearchAndMarkets.com's offering. The hosted private branch exchange (PBX) market is experiencing significant growth, with projections indicating a rise from $14.44 billion in 2024 to $16.81 billion in 2025, at a CAGR of 16.4%. This growth is driven by increasing demand for centralized communication systems, internet-based operations, and OPEX-based telephony models. A focus on reducing hardware...

$9.17 Bn Cancer Antibody Drug Conjugates Global Markets, 2019-2024, 2024-2029F, 2034F - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cancer Antibody Drug Conjugates Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The global cancer antibody drug conjugates market is experiencing significant expansion, with a projected increase from $8.19 billion in 2024 to $9.17 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.9%. This growth has been fueled by the rising incidence of cancer globally, increased healthcare spending, demand for targeted treatmen...
Back to Newsroom